A porous material for bone ingrowth with adequate pore structure and appropriate mechanical properties has long been sought as the ideal bone-implant interface. This study aimed to assess in vivo the ...

Stryker just notched a win by snagging FDA clearance for its Incompass Total Ankle System, aimed at treating severe arthritis ...

Stryker Corporation (NYSE:SYK) ranks among the best set-it-and-forget-it stocks to buy. On June 25, Stryker Corporation (NYSE ...

Different synthesis methods of calcium phosphate (CaP) have been developed with diverse crystalline structures and morphology, as well as processed 3D scaffolds to stimulate bone ingrowth into ...

Stryker has received 510(k) clearance from the FDA for its Incompass Total Ankle System, a next-generation implant targeting patients with severe ankle arthritis. This all-in-one system combines the ...

FDA grants 510 (k) clearance to Stryker’s total ankle system The system features Adaptis Boney Ingrowth Technology and redesigned instrumentation.

Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe arthritis-related ankle joint damage.